Pythium insidiosum is an oomycete pathogenic in mammals. The infection occurs mainly in
tropical and subtropical areas, particularly in horses, dogs and humans. Infection is acquired …

Fungal infections are estimated to be responsible for 1.5 million deaths annually. Global anti-
microbial resistance is also observed for fungal pathogens, and scientists are looking for …

Purpose: To study the demographic profile, clinical features, treatment outcome, and ocular
morbidity of microbiologically proven Pythium keratitis in South India. Methods: A …

Purpose: To report the molecular and microbiological diagnosis and clinical profile of 13
patients with Pythium insidiosum keratitis. Methods: Phase 1 of the study consisted of DNA …

Nonsteroidal anti-inflammatory drugs (NSAIDs) are an important class of anti-inflammatory
drugs widely used for the treatment of musculoskeletal disorders, mild-to-moderate pain …

Pythiosis is a life-threatening infectious disease of humans and animals caused by the
oomycete microorganism Pythium insidiosum. The disease has been increasingly …

We have determined the in vitro activity of several antibacterial and antifungal drugs against
Pythium insidiosum using broth microdilution (BMD), disk diffusion, and Etest methods. The …

Purpose: To describe typical clinical and laboratory characteristics of severe fungal keratitis
caused by Pythium insidiosum during the rainy season in Northeast Thailand and to report …

We describe the in vitro activities of the combinations of carvacrol and thymol with antibiotics
(azithromycin, clarithromycin, minocycline and tigecycline) and antifungal agents …

We describe the in vitro activity of macrolides and tetracycline antibiotics against Pythium
insidiosum. The MICs were determined according to CLSI procedures (visual MIC) and by a …